Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001013762-14-001191
Filing Date
2014-10-08
Accepted
2014-10-08 14:23:27
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 form10qa.htm 10-Q/A 594003
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER ex311.htm EX-31.1 10208
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER ex312.htm EX-31.2 10244
4 CERTIFICATION PURSUANT TO ex321.htm EX-32.1 5238
5 CERTIFICATION PURSUANT TO ex322.htm EX-32.2 5300
  Complete submission text file 0001013762-14-001191.txt   5551079

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE svfc-20130930.xml EX-101.INS 889557
7 XBRL SCHEMA FILE svfc-20130930.xsd EX-101.SCH 58152
8 XBRL CALCULATION FILE svfc-20130930_cal.xml EX-101.CAL 54371
9 XBRL DEFINITION FILE svfc-20130930_def.xml EX-101.DEF 171122
10 XBRL LABEL FILE svfc-20130930_lab.xml EX-101.LAB 300567
11 XBRL PRESENTATION FILE svfc-20130930_pre.xml EX-101.PRE 243242
Mailing Address 30 EAST 76TH STREET, 6TH FLOOR NEW YORK NY 10021
Business Address 30 EAST 76TH STREET, 6TH FLOOR NEW YORK NY 10021 (212) 249-3050
Intellicell Biosciences, Inc. (Filer) CIK: 0001125280 (see all company filings)

EIN.: 911966948 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-54729 | Film No.: 141147623
SIC: 2836 Biological Products, (No Diagnostic Substances)